City

Santa Monica (1)

Condition

Advanced Cancer (1)

Advanced Solid Tumor (1)

Metastatic Cancer (1)

Recurrent Cancer (1)

Refractory Cancer (1)

Solid Tumor, Adult (1)

Unresectable Carcinoma (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

NKGen Biotech, Inc. (1)

Collaborator

Intervention

avelumab (1)

pembrolizumab (1)

snk01 (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

unresectable carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)

Active, not recruiting

Refractory Cancer
+6 more

SNK01
+2 more

Santa Monica, California

Sarcoma Oncology Research Center

Sep 25, 2022